Overview Dividends

(ACLS) Axcelis Technologies - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0545402085

Ion Implanters, Drying

ACLS EPS (Earnings per Share)

EPS Growth (3Y CAGR): -59.57%
EPS Trend (3Y Correlation): -68.3%

ACLS Revenue

Revenue Growth (3Y CAGR): -5.78%
Revenue Trend (3Y Correlation): -50.2%

Description: ACLS Axcelis Technologies August 09, 2025

Axcelis Technologies Inc (NASDAQ:ACLS) is a US-based company operating in the Semiconductor Materials & Equipment sub-industry. To evaluate its investment potential, we need to deconstruct its financial performance and identify key drivers.

The companys Income Tax Expense is a critical component of its financial statements, influencing its Net Income and ultimately, its Earnings Per Share (EPS). A thorough analysis of the yearly Income Tax Expense can reveal trends and anomalies that may impact ACLSs valuation.

Key Performance Indicators (KPIs) to monitor include the companys tax rate, EPS growth, and Return on Equity (RoE), currently standing at 18.02%. The Price-to-Earnings (P/E) ratio is 12.98, suggesting a relatively reasonable valuation compared to its earnings. The Forward P/E of 14.18 indicates expected earnings growth.

Economic drivers influencing ACLSs performance include the demand for semiconductor equipment, driven by the growth of the global semiconductor industry, advancements in technology, and the increasing need for miniaturization and performance enhancements. The companys Market Capitalization of $2.277 billion USD is a relevant metric to assess its size and market influence.

To further analyze ACLSs potential, we should examine its revenue growth, gross margin, and operating expenses, as well as the competitive landscape and industry trends. By identifying leverage points and designing targeted interventions, we can optimize our investment strategy.

ACLS Stock Overview

Market Cap in USD	2,627m
Sub-Industry	Semiconductor Materials & Equipment
IPO / Inception	2000-07-11

ACLS Stock Ratings

Growth Rating	33.2%
Fundamental	60.8%
Dividend Rating	-
Return 12m vs S&P 500	-20.4%
Analyst Rating	3.57 of 5

ACLS Dividends

Currently no dividends paid

ACLS Growth Ratios

Growth Correlation 3m	64.7%
Growth Correlation 12m	23.1%
Growth Correlation 5y	55.3%
CAGR 5y	13.88%
CAGR/Max DD 3y (Calmar Ratio)	0.18
CAGR/Mean DD 3y (Pain Ratio)	0.37
Sharpe Ratio 12m	-0.30
Alpha	-33.45
Beta	1.752
Volatility	48.07%
Current Volume	517.1k
Average Volume 20d	609.6k
Stop Loss	79.9 (-5.3%)
Signal	0.46

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (158.5m TTM) > 0 and > 6% of Revenue (6% = 53.8m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -2.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 99.03% (prev 75.05%; Δ 23.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.10 (>3.0%) and CFO 138.1m <= Net Income 158.5m (YES >=105%, WARN >=100%)

Net Debt (-130.6m) to EBITDA (204.6m) ratio: -0.64 <= 3.0 (WARN <= 3.5)

Current Ratio 6.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (32.1m) change vs 12m ago -2.04% (target <= -2.0% for YES)

Gross Margin 44.90% (prev 44.63%; Δ 0.27pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 68.62% (prev 86.27%; Δ -17.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 34.11 (EBITDA TTM 204.6m / Interest Expense TTM 5.50m) >= 6 (WARN >= 3)

Altman Z'' 8.26

(A) 0.67 = (Total Current Assets 1.06b - Total Current Liabilities 177.1m) / Total Assets 1.32b

(B) 0.37 = Retained Earnings (Balance) 487.2m / Total Assets 1.32b

(D) 1.62 = Book Value of Equity 486.7m / Total Liabilities 301.1m

Total Rating: 8.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.75

1. Piotroski 4.50pt = -0.50

2. FCF Yield 6.13% = 3.07

3. FCF Margin 14.52% = 3.63

4. Debt/Equity 0.04 = 2.50

5. Debt/Ebitda -0.64 = 2.50

6. ROIC - WACC (= 4.35)% = 5.43

7. RoE 15.70% = 1.31

8. Rev. Trend -50.23% = -3.77

9. EPS Trend -68.35% = -3.42

What is the price of ACLS shares?

As of October 24, 2025, the stock is trading at USD 84.36 with a total of 517,107 shares traded.
Over the past week, the price has changed by +0.88%, over one month by -14.33%, over three months by +12.72% and over the past year by -6.31%.

Is Axcelis Technologies a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Axcelis Technologies is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 60.75 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACLS is around 77.42 USD . This means that ACLS is currently overvalued and has a potential downside of -8.23%.

Is ACLS a buy, sell or hold?

Axcelis Technologies has received a consensus analysts rating of 3.57. Therefor, it is recommend to hold ACLS.

Strong Buy: 2
Buy: 0
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ACLS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	97	15%
Analysts Target Price	97	15%
ValueRay Target Price	89.3	5.8%

ACLS Fundamental Data Overview October 17, 2025

Market Cap USD = 2.63b (2.63b USD * 1.0 USD.USD)
P/E Trailing = 17.0653
P/E Forward = 25.4453
P/S = 2.9319
P/B = 2.8755
P/EG = 1.23
Beta = 1.752
Revenue TTM = 896.1m USD
EBIT TTM = 187.6m USD
EBITDA TTM = 204.6m USD
Long Term Debt = 42.3m USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 1.44m USD (from shortTermDebt, last quarter)
Debt = 43.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -130.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.12b USD (2.63b + Debt 43.0m - CCE 549.8m)
Interest Coverage Ratio = 34.11 (Ebit TTM 187.6m / Interest Expense TTM 5.50m)
FCF Yield = 6.13% (FCF TTM 130.1m / Enterprise Value 2.12b)
FCF Margin = 14.52% (FCF TTM 130.1m / Revenue TTM 896.1m)
Net Margin = 17.69% (Net Income TTM 158.5m / Revenue TTM 896.1m)
Gross Margin = 44.90% ((Revenue TTM 896.1m - Cost of Revenue TTM 493.8m) / Revenue TTM)
Gross Margin QoQ = 44.90% (prev 46.10%)
Tobins Q-Ratio = 1.60 (Enterprise Value 2.12b / Total Assets 1.32b)
Interest Expense / Debt = 3.15% (Interest Expense 1.35m / Debt 43.0m)
Taxrate = 10.35% (3.62m / 35.0m)
NOPAT = 168.2m (EBIT 187.6m * (1 - 10.35%))
Current Ratio = 6.01 (Total Current Assets 1.06b / Total Current Liabilities 177.1m)
Debt / Equity = 0.04 (Debt 43.0m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = -0.64 (Net Debt -130.6m / EBITDA 204.6m)
Debt / FCF = -1.00 (Net Debt -130.6m / FCF TTM 130.1m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.97% (Net Income 158.5m / Total Assets 1.32b)
RoE = 15.70% (Net Income TTM 158.5m / Total Stockholder Equity 1.01b)
RoCE = 17.83% (EBIT 187.6m / Capital Employed (Equity 1.01b + L.T.Debt 42.3m))
RoIC = 16.66% (NOPAT 168.2m / Invested Capital 1.01b)
WACC = 12.31% (E(2.63b)/V(2.67b) * Re(12.47%) + D(43.0m)/V(2.67b) * Rd(3.15%) * (1-Tc(0.10)))
Discount Rate = 12.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.41%
[DCF Debug] Terminal Value 63.19% ; FCFE base≈139.2m ; Y1≈135.2m ; Y5≈135.3m
Fair Price DCF = 41.18 (DCF Value 1.29b / Shares Outstanding 31.4m; 5y FCF grow -4.01% → 3.0% )
EPS Correlation: -68.35 | EPS CAGR: -59.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: -50.23 | Revenue CAGR: -5.78% | SUE: 1.98 | # QB: 3

Additional Sources for ACLS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle